Trials / Suspended
SuspendedNCT06095011
Posture Correction in Cubital Tunnel Syndrome
Posture Correction for the Treatment of Cubital Tunnel Syndrome (CuTS)
- Status
- Suspended
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to determine whether the UpRight Go posture trainer reduces the symptoms of cubital tunnel syndrome in patients who have not had corrective surgery, as determined by improvements in VAS scores for pain, numbness, and weakness.
Detailed description
This is a randomized controlled, non-blinded trial. All patients who are eligible to participate and who consent to participate will be randomized to either receive standard of care treatment alone, or standard of care treatment with the additional intervention of posture training. The nature of the intervention prevents blinding. All patients will be followed for 6 weeks and evaluated for symptom improvement or resolution. All patients aged 18 and older who present to clinic with cubital tunnel syndrome of any severity and who have not previously undergone surgical intervention for this condition will be eligible to participate in this study. All participants must be amenable to conservative management of CuTS, wearing a posture training device daily, completing the accompanying questionnaires throughout the study, and returning for follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | UpRight Go | The UpRight Go posture trainer is a commercially available biofeedback sensor that externally attaches to the wearer via a necklace or silicon adhesive. It vibrates when it senses that the wearer is slouching and connects to a smartphone application which sets daily goals, tracks usage, and provides assistance and support. It complies with International Electrotechnical Commission (IEC) standards. |
Timeline
- Start date
- 2023-12-15
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2023-10-23
- Last updated
- 2025-09-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06095011. Inclusion in this directory is not an endorsement.